adalimumab Injectable Product
RxNorm concept 1163691, clinical dose form group (scdg).
- RxCUI
- 1163691
- Term type
- Clinical dose form group (SCDG)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1163691 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Related concepts
- adalimumab (IN, has ingredient)
- Humira Injectable Product (SBDG, has tradename)
- Amjevita Injectable Product (SBDG, has tradename)
- Yuflyma Injectable Product (SBDG, has tradename)
- Hadlima Injectable Product (SBDG, has tradename)
- Yusimry Injectable Product (SBDG, has tradename)
- Hulio Injectable Product (SBDG, has tradename)
- Idacio Injectable Product (SBDG, has tradename)
- Cyltezo Injectable Product (SBDG, has tradename)
- Hyrimoz Injectable Product (SBDG, has tradename)
- Abrilada Injectable Product (SBDG, has tradename)
- Simlandi Injectable Product (SBDG, has tradename)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 1163691 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1163691 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1163691. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.